Navigating Clinical Development Pathways to Commercial Approval: Pfizer’s Success with BEQVEZ Gene Therapy for Hemophilia B

Time: 12:30 pm
day: Day 2- Clinical 1

Details:

  • Insights into Pfizer’s journey to regulatory approval in the U.S., EU, and Canada, addressing unique challenges and breakthrough solutions for BEQVEZ
  • Exploration of risk minimization and safety and efficacy control measures that underpin the commercialization of BEQVEZ
  • In-depth examples of product comparability and process characterization that supported BEQVEZ’s development and commercialization as a transformative therapy

Speakers: